









Markets
/
Stocks
/
nasdaq-plyx
/

Polaryx Therapeutics Ord Shs

PLYX

7.805USD

+1.525+24.28%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

369.51MMarket Cap

LossP/E TTM



Polaryx Therapeutics Ord Shs

7.805

+1.525+24.28%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

You can check out the annual or quarterly balance sheets of Polaryx Therapeutics Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total equity

Cash, cash equivalents and short-term investments

--5.75M

- Cash and cash equivalents

--5.75M

Prepaid expenses

--82.00K

Other current assets

--156.00K

Total current assets

--5.98M

Non-current assets

Total assets

--5.98M

Liabilities

Current liabilities

-Other payables

--178.00K

Accrued expenses

--8.00K

Other current liabilities

--178.00K

Total current liabilities

--682.00K

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Total liabilities

--682.00K

Shareholders' equity

Common equity

--103.44M

Retained earnings

---98.14M

Capital reserves

--103.44M

Total equity

--5.30M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

